tm
Seeing Is Believing
tm
Seeing Is Believing
DYN is currently covered by 12 analysts with an average price target of $41.1. This is a potential upside of $22.81 (124.71%) from yesterday's end of day stock price of $18.29.
Dyne Therapeutics 's activity chart (see below) currently has 93 price targets and 100 ratings on display. The stock rating distribution of DYN is 77.14% BUY and 22.86% HOLD.
Analysts average stock forecasts to be materialized ratio is 42.12% with an average time for these price targets to be met of 204.87 days.
Highest price target for DYN is $60, Lowest price target is $16, average price target is $38.36.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 09-Mar-2026. First documented stock forecast 12-Oct-2020.
5/25/10 1 for 5
8/22/00 2 for 1
2/1/00 69 for 100
Currently out of the existing stock ratings of DYN, 27 are a BUY (77.14%), 8 are a HOLD (22.86%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Jul-2022
$38
$20.08 (112.05%)
$38
10 days ago
(09-Mar-2026)
6/14 (42.86%)
$20.31 (114.81%)
197
Buy Since 30-Apr-2024
$47
$29.08 (162.28%)
$52
16 days ago
(03-Mar-2026)
1/3 (33.33%)
$30.85 (191.02%)
72
Hold Since 24-Oct-2024
$16
$-1.92 (-10.71%)
$17
1 months 27 days ago
(20-Jan-2026)
10/11 (90.91%)
$-0.58 (-3.50%)
97
Buy Since 12-Oct-2020
$39
$21.08 (117.63%)
$36
3 months 8 days ago
(11-Dec-2025)
5/9 (55.56%)
$19.58 (100.82%)
418
Buy Since 10-Dec-2025
$40
$22.08 (123.21%)
$11
3 months 9 days ago
(10-Dec-2025)
1/5 (20%)
$20.31 (103.15%)
19
What is DYN (Dyne Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on DYN (Dyne Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on DYN (Dyne Therapeutics )?
Which analyst is the currently most bullish on DYN (Dyne Therapeutics )?
Which analyst is the currently most reserved on DYN (Dyne Therapeutics )?
